{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:23:31Z","timestamp":1792653811684,"version":"4.5.0"},"reference-count":118,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T00:00:00Z","timestamp":1650758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI107960"],"award-info":[{"award-number":["AI107960"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The expression of cytokines and chemokines in response to adenovirus infection is tightly regulated by the innate immune system. Cytokine-mediated toxicity and cytokine storm are known clinical phenomena observed following naturally disseminated adenovirus infection in immunocompromised hosts as well as when extremely high doses of adenovirus vectors are injected intravenously. This dose-dependent, cytokine-mediated toxicity compromises the safety of adenovirus-based vectors and represents a critical problem, limiting their utility for gene therapy applications and the therapy of disseminated cancer, where intravenous injection of adenovirus vectors may provide therapeutic benefits. The mechanisms triggering severe cytokine response are not sufficiently understood, prompting efforts to further investigate this phenomenon, especially in clinically relevant settings. In this review, we summarize the current knowledge on cytokine and chemokine activation in response to adenovirus- and adenovirus-based vectors and discuss the underlying mechanisms that may trigger acute cytokine storm syndrome. First, we review profiles of cytokines and chemokines that are activated in response to adenovirus infection initiated via different routes. Second, we discuss the molecular mechanisms that lead to cytokine and chemokine transcriptional activation. We further highlight how immune cell types in different organs contribute to synthesis and systemic release of cytokines and chemokines in response to adenovirus sensing. Finally, we review host factors that can limit cytokine and chemokine expression and discuss currently available and potential future interventional approaches that allow for the mitigation of the severity of the cytokine storm syndrome. Effective cytokine-targeted interventional approaches may improve the safety of systemic adenovirus delivery and thus broaden the potential clinical utility of adenovirus-based therapeutic vectors.<\/jats:p>","DOI":"10.3390\/v14050888","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T02:14:39Z","timestamp":1650939279000},"page":"888","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Cytokine Responses to Adenovirus and Adenovirus Vectors"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7816-393X","authenticated-orcid":false,"given":"Svetlana","family":"Atasheva","sequence":"first","affiliation":[{"name":"Lowance Center for Human Immunology, Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8320-9007","authenticated-orcid":false,"given":"Dmitry M.","family":"Shayakhmetov","sequence":"additional","affiliation":[{"name":"Lowance Center for Human Immunology, Departments of Pediatrics and Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA"},{"name":"Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA"},{"name":"Discovery and Developmental Therapeutics Program, Winship Cancer Institute of Emory University, Atlanta, GA 30322, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,4,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri.2017.136","article-title":"Peptidoglycan recognition by the innate immune system","volume":"18","author":"Wolf","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature06246","article-title":"Recognition of microorganisms and activation of the immune response","volume":"449","author":"Medzhitov","year":"2007","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41577-019-0131-x","article-title":"Cytokine-mediated communication: A quantitative appraisal of immune complexity","volume":"19","author":"Mukherjee","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-immunol-041015-055649","article-title":"Chemokines and Chemokine Receptors in Lymphoid Tissue Dynamics","volume":"34","author":"Schulz","year":"2016","journal-title":"Annu. Rev. Immunol."},{"key":"ref_8","first-page":"491","article-title":"Macrophage cytokines: Involvement in immunity and infectious diseases","volume":"5","author":"Descoteaux","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: An interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against COVID-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1172\/JCI78280","article-title":"Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling","volume":"125","author":"Quinn","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2003.08.016","article-title":"Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer","volume":"80","author":"Raper","year":"2003","journal-title":"Mol. Genet. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-0036-1584923","article-title":"Adenovirus: Epidemiology, Global Spread of Novel Serotypes, and Advances in Treatment and Prevention","volume":"37","author":"Lynch","year":"2016","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"614781","DOI":"10.3389\/fimmu.2020.614781","article-title":"Plasma TNFSF13B and TNFSF14 Function as Inflammatory Indicators of Severe Adenovirus Pneumonia in Pediatric Patients","volume":"11","author":"Fan","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"691879","DOI":"10.3389\/fimmu.2021.691879","article-title":"Cytokine\/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/infdis\/jiaa524","article-title":"Clinical Features, Replication Competence, and Innate Immune Responses of Human Adenovirus Type 7 Infection","volume":"223","author":"Chen","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"551413","DOI":"10.3389\/fimmu.2020.551413","article-title":"Adenovirus 7 Induces Interlukin-6 Expression in Human Airway Epithelial Cells via p38\/NF-kappaB Signaling Pathway","volume":"11","author":"Qi","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Radke, J.R., Covert, H.J., Bauer, F., Ananthanarayanan, V., and Cook, J.L. (2020). Adenovirus 14p1 Immunopathogenesis during Lung Infection in the Syrian Hamster. Viruses, 12.","DOI":"10.3390\/v12060595"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/JVI.01790-15","article-title":"Low-Level Expression of the E1B 20-Kilodalton Protein by Adenovirus 14p1 Enhances Viral Immunopathogenesis","volume":"90","author":"Radke","year":"2016","journal-title":"J. Virol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virol.2017.04.005","article-title":"Contributions of CD8 T cells to the pathogenesis of mouse adenovirus type 1 respiratory infection","volume":"507","author":"Molloy","year":"2017","journal-title":"Virology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fimmu.2018.00049","article-title":"Fowl Adenovirus Serotype 4 SD0828 Infections Causes High Mortality Rate and Cytokine Levels in Specific Pathogen-Free Chickens Compared to Ducks","volume":"9","author":"Li","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/ni.3503","article-title":"Interleukin 1alpha and the inflammatory process","volume":"17","author":"Shayakhmetov","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) COVID-19 Vaccine","volume":"385","author":"Falsey","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.2021.8565","article-title":"Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial","volume":"326","author":"Zhang","year":"2021","journal-title":"JAMA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"579872","DOI":"10.3389\/fimmu.2020.579872","article-title":"Innate Immune Responses to Chimpanzee Adenovirus Vector 155 Vaccination in Mice and Monkeys","volume":"11","author":"Collignon","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9590","DOI":"10.1128\/JVI.00740-12","article-title":"Vaccination with adenovirus serotypes 35, 26, and 48 elicits higher levels of innate cytokine responses than adenovirus serotype 5 in rhesus monkeys","volume":"86","author":"Teigler","year":"2012","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1128\/JVI.01392-12","article-title":"Circulating antibodies and macrophages as modulators of adenovirus pharmacology","volume":"87","author":"Khare","year":"2013","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"11705","DOI":"10.1128\/JVI.01320-08","article-title":"Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement","volume":"82","author":"Xu","year":"2008","journal-title":"J. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.immuni.2009.04.015","article-title":"Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo","volume":"31","author":"Miao","year":"2009","journal-title":"Immunity"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Di Paolo, N.C., Baldwin, L.K., Irons, E.E., Papayannopoulou, T., Tomlinson, S., and Shayakhmetov, D.M. (2014). IL-1alpha and complement cooperate in triggering local neutrophilic inflammation in response to adenovirus and eliminating virus-containing cells. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004035"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1128\/JVI.76.4.1559-1568.2002","article-title":"Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10","volume":"76","author":"Tibbles","year":"2002","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"eabc6659","DOI":"10.1126\/scitranslmed.abc6659","article-title":"Systemic cancer therapy with engineered adenovirus that evades innate immunity","volume":"12","author":"Atasheva","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1126\/science.1226625","article-title":"Coagulation factor X activates innate immunity to human species C adenovirus","volume":"338","author":"Doronin","year":"2012","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.celrep.2013.05.025","article-title":"The transcription factor IRF3 triggers \"defensive suicide\" necrosis in response to viral and bacterial pathogens","volume":"3","author":"Doronin","year":"2013","journal-title":"Cell Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.4049\/jimmunol.181.3.2134","article-title":"Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo","volume":"181","author":"Appledorn","year":"2008","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"9655","DOI":"10.1128\/JVI.74.20.9655-9667.2000","article-title":"Internalization of adenovirus by alveolar macrophages initiates early proinflammatory signaling during acute respiratory tract infection","volume":"74","author":"Zsengeller","year":"2000","journal-title":"J. Virol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.4049\/jimmunol.174.11.7310","article-title":"Interference with the IL-1-signaling pathway improves the toxicity profile of systemically applied adenovirus vectors","volume":"174","author":"Shayakhmetov","year":"2005","journal-title":"J. Immunol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/gt.2008.114","article-title":"Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors","volume":"15","author":"Appledorn","year":"2008","journal-title":"Gene Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/mthe.2001.0329","article-title":"Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages","volume":"3","author":"Zhang","year":"2001","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/mt.2012.162","article-title":"Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery","volume":"20","author":"Coughlan","year":"2012","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1158\/0008-5472.CAN-14-3761","article-title":"Pharmacological Inhibition of beta3 Integrin Reduces the Inflammatory Toxicities Caused by Oncolytic Adenovirus without Compromising Anticancer Activity","volume":"75","author":"Browne","year":"2015","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Fejer, G., Drechsel, L., Liese, J., Schleicher, U., Ruzsics, Z., Imelli, N., Greber, U.F., Keck, S., Hildenbrand, B., and Krug, A. (2008). Key role of splenic myeloid DCs in the IFN-alphabeta response to adenoviruses in vivo. PLoS Pathog., 4.","DOI":"10.1371\/journal.ppat.1000208"},{"key":"ref_44","first-page":"6070","article-title":"Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): Phase II viral, immunologic, and clinical endpoints","volume":"62","author":"Reid","year":"2002","journal-title":"Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/sj.cgt.7700870","article-title":"Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial","volume":"13","author":"Atencio","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40425-019-0510-7","article-title":"A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)","volume":"7","author":"Machiels","year":"2019","journal-title":"J. Immuno Ther. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ymthe.2006.02.011","article-title":"A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer","volume":"14","author":"Small","year":"2006","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1089\/hum.2018.107","article-title":"A Phase 1 Trial of Oncolytic Adenovirus ICOVIR-5 Administered Intravenously to Cutaneous and Uveal Melanoma Patients","volume":"30","author":"Garcia","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40425-016-0121-5","article-title":"Phase I study with ONCOS-102 for the treatment of solid tumors\u2014An evaluation of clinical response and exploratory analyses of immune markers","volume":"4","author":"Ranki","year":"2016","journal-title":"J. Immuno Ther. Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.cgt.7700568","article-title":"A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma","volume":"10","author":"Khorana","year":"2003","journal-title":"Cancer Gene Ther."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejca.2021.04.043","article-title":"Phase I dose-escalation study of endoscopic intratumoral injection of OBP-301 (Telomelysin) with radiotherapy in oesophageal cancer patients unfit for standard treatments","volume":"153","author":"Shirakawa","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/sj.mt.6300396","article-title":"A phase I trial of Ad.hIFN-beta gene therapy for glioma","volume":"16","author":"Chiocca","year":"2008","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"10354","DOI":"10.1128\/JVI.00936-14","article-title":"Late endosomal trafficking of alternative serotype adenovirus vaccine vectors augments antiviral innate immunity","volume":"88","author":"Teigler","year":"2014","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1126\/science.aax8819","article-title":"MAIT cell activation augments adenovirus vector vaccine immunogenicity","volume":"371","author":"Provine","year":"2021","journal-title":"Science"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Tran, T.T.P., Eichholz, K., Amelio, P., Moyer, C., Nemerow, G.R., Perreau, M., Mennechet, F.J.D., and Kremer, E.J. (2018). Humoral immune response to adenovirus induce tolerogenic bystander dendritic cells that promote generation of regulatory T cells. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1007127"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1002\/1873-3468.13696","article-title":"Innate immunity to adenovirus: Lessons from mice","volume":"593","author":"Atasheva","year":"2019","journal-title":"FEBS Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-kappaB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4049\/jimmunol.1300344","article-title":"Synergistic expression of the CXCL10 gene in response to IL-1beta and IFN-gamma involves NF-kappaB, phosphorylation of STAT1 at Tyr701, and acetylation of histones H3 and H4","volume":"191","author":"Burke","year":"2013","journal-title":"J. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1128\/JVI.02192-06","article-title":"Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways","volume":"81","author":"Zhu","year":"2007","journal-title":"J. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/jgm.964","article-title":"Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production","volume":"8","author":"Gaffal","year":"2006","journal-title":"J. Gene Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: Sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ni.3433","article-title":"S6K-STING interaction regulates cytosolic DNA-mediated activation of the transcription factor IRF3","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.1128\/JVI.00500-16","article-title":"Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS\/STING-Deficient Mice Minimally Impacts Adaptive Immunity","volume":"90","author":"Anghelina","year":"2016","journal-title":"J. Virol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/intimm\/dxv058","article-title":"TANK-binding kinase 1-dependent or -independent signaling elicits the cell-type-specific innate immune responses induced by the adenovirus vector","volume":"28","author":"Tsuzuki","year":"2016","journal-title":"Int. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-018-05559-w","article-title":"ZCCHC3 is a co-sensor of cGAS for dsDNA recognition in innate immune response","volume":"9","author":"Lian","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"eaav0758","DOI":"10.1126\/science.aav0758","article-title":"Nuclear hnRNPA2B1 initiates and amplifies the innate immune response to DNA viruses","volume":"365","author":"Wang","year":"2019","journal-title":"Science"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"108297","DOI":"10.1016\/j.celrep.2020.108297","article-title":"MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway","volume":"33","author":"Tian","year":"2020","journal-title":"Cell Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/hum.2009.155","article-title":"MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to helper-dependent adenovirus","volume":"21","author":"Suzuki","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1128\/JVI.01265-10","article-title":"Adenovirus membrane penetration activates the NLRP3 inflammasome","volume":"85","author":"Barlan","year":"2011","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature06664","article-title":"The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response","volume":"452","author":"Muruve","year":"2008","journal-title":"Nature"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Smith, J.S., Xu, Z., Tian, J., Palmer, D.J., Ng, P., and Byrnes, A.P. (2011). The role of endosomal escape and mitogen-activated protein kinases in adenoviral activation of the innate immune response. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026755"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1743-422X-5-17","article-title":"Human adenovirus type 19 infection of corneal cells induces p38 MAPK-dependent interleukin-8 expression","volume":"5","author":"Rajaiya","year":"2008","journal-title":"Virol. J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"14507","DOI":"10.1128\/JVI.79.23.14507-14515.2005","article-title":"Akt\/protein kinase B activation by adenovirus vectors contributes to NFkappaB-dependent CXCL10 expression","volume":"79","author":"Liu","year":"2005","journal-title":"J. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1089\/hum.2011.002","article-title":"NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo","volume":"22","author":"Suzuki","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Punga, T., Darweesh, M., and Akusjarvi, G. (2020). Synthesis, Structure, and Function of Human Adenovirus Small Non-Coding RNAs. Viruses, 12.","DOI":"10.3390\/v12101182"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.3389\/fimmu.2019.02791","article-title":"Adenovirus VA RNAI Blocks ASC Oligomerization and Inhibits NLRP3 Inflammasome Activation","volume":"10","author":"Darweesh","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/nar\/gkab896","article-title":"Adenovirus prevents dsRNA formation by promoting efficient splicing of viral RNA","volume":"50","author":"Price","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Zeng, X., and Carlin, C.R. (2019). Adenovirus early region 3 RIDalpha protein limits NFkappaB signaling through stress-activated EGF receptors. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1008017"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1128\/JVI.79.4.1992-2000.2005","article-title":"Adenovirus protein VI mediates membrane disruption following capsid disassembly","volume":"79","author":"Wiethoff","year":"2005","journal-title":"J. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1189\/jlb.0612311","article-title":"CRIg mediates early Kupffer cell responses to adenovirus","volume":"93","author":"He","year":"2013","journal-title":"J. Leukoc. Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1021\/mp8000974","article-title":"Scavenger receptor A: A new route for adenovirus 5","volume":"6","author":"Haisma","year":"2009","journal-title":"Mol. Pharm."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/JVI.05760-11","article-title":"Identification of adenovirus serotype 5 hexon regions that interact with scavenger receptors","volume":"86","author":"Khare","year":"2012","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ymthe.2005.08.007","article-title":"Rapid Kupffer cell death after intravenous injection of adenovirus vectors","volume":"13","author":"Manickan","year":"2006","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/mt.2008.307","article-title":"Redundant and synergistic mechanisms control the sequestration of blood-born adenovirus in the liver","volume":"17","author":"Shayakhmetov","year":"2009","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1099\/vir.0.008342-0","article-title":"Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN","volume":"90","author":"Adams","year":"2009","journal-title":"J. Gen. Virol."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Eichholz, K., Bru, T., Tran, T.T., Fernandes, P., Welles, H., Mennechet, F.J., Manel, N., Alves, P., Perreau, M., and Kremer, E.J. (2016). Immune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic Cells. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005871"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ymthe.2020.01.006","article-title":"Adenovirus-Antibody Complexes Contributed to Lethal Systemic Inflammation in a Gene Therapy Trial","volume":"28","author":"Somanathan","year":"2020","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ncomms1391","article-title":"Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells","volume":"2","author":"Lutschg","year":"2011","journal-title":"Nat. Commun."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/08830185.2013.823420","article-title":"Adenoviruses types, cell receptors and local innate cytokines in adenovirus infection","volume":"33","author":"Chen","year":"2014","journal-title":"Int. Rev. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat. Med."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Smith, J.G., Silvestry, M., Lindert, S., Lu, W., Nemerow, G.R., and Stewart, P.L. (2010). Insight into the mechanisms of adenovirus capsid disassembly from studies of defensin neutralization. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000959"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Tartaglia, L.J., Badamchi-Zadeh, A., Abbink, P., Blass, E., Aid, M., Gebre, M.S., Li, Z., Pastores, K.C., Trott, S., and Gupte, S. (2019). Alpha-defensin 5 differentially modulates adenovirus vaccine vectors from different serotypes in vivo. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1008180"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1099\/vir.0.030965-0","article-title":"CD209\/DC-SIGN mediates efficient infection of monocyte-derived dendritic cells by clinical adenovirus 2C isolates in the presence of bovine lactoferrin","volume":"92","author":"Gunther","year":"2011","journal-title":"J. Gen. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.3107","article-title":"Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement","volume":"19","author":"Xu","year":"2013","journal-title":"Nat. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/JVI.03576-14","article-title":"Human coagulation factor X-adenovirus type 5 complexes poorly stimulate an innate immune response in human mononuclear phagocytes","volume":"89","author":"Eichholz","year":"2015","journal-title":"J. Virol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7058","DOI":"10.4049\/jimmunol.0804269","article-title":"Antiviral antibodies target adenovirus to phagolysosomes and amplify the innate immune response","volume":"182","author":"Zaiss","year":"2009","journal-title":"J. Immunol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Watkinson, R.E., McEwan, W.A., Tam, J.C., Vaysburd, M., and James, L.C. (2015). TRIM21 Promotes cGAS and RIG-I Sensing of Viral Genomes during Infection by Antibody-Opsonized Virus. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005253"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.gt.3302347","article-title":"Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice","volume":"12","author":"Varnavski","year":"2005","journal-title":"Gene Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1128\/JVI.76.11.5711-5719.2002","article-title":"Preexisting immunity to adenovirus in rhesus monkeys fails to prevent vector-induced toxicity","volume":"76","author":"Varnavski","year":"2002","journal-title":"J. Virol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/mt.2009.156","article-title":"Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster model","volume":"17","author":"Dhar","year":"2009","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1128\/JVI.00082-09","article-title":"Adenovirus activates complement by distinctly different mechanisms in vitro and in vivo: Indirect complement activation by virions in vivo","volume":"83","author":"Tian","year":"2009","journal-title":"J. Virol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.chom.2019.02.016","article-title":"Complement C4 Prevents Viral Infection through Capsid Inactivation","volume":"25","author":"Bottermann","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Emerson, C.C., and Stewart, P.L. (2021). Structure-Based Modeling of Complement C4 Mediated Neutralization of Adenovirus. Viruses, 13.","DOI":"10.3390\/v13010111"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"675897","DOI":"10.3389\/fimmu.2021.675897","article-title":"Challenges Posed by Immune Responses to AAV Vectors: Addressing Root Causes","volume":"12","author":"Hamilton","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2020.00670","article-title":"Human Immune Responses to Adeno-Associated Virus (AAV) Vectors","volume":"11","author":"Ronzitti","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy\u2014Assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1634\/theoncologist.2018-0028","article-title":"FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome","volume":"23","author":"Le","year":"2018","journal-title":"Oncologist"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1182\/bloodadvances.2020002328","article-title":"Clinical efficacy of anakinra to mitigate CAR T-cell therapy-associated toxicity in large B-cell lymphoma","volume":"4","author":"Strati","year":"2020","journal-title":"Blood Adv."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.omtm.2021.12.003","article-title":"Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5\/35++ vectors","volume":"24","author":"Li","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"eabd4235","DOI":"10.1126\/sciadv.abd4235","article-title":"TRAF6-IRF5 kinetics, TRIF, and biophysical factors drive synergistic innate responses to particle-mediated MPLA-CpG co-presentation","volume":"7","author":"Pradhan","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Betker, J.L., and Anchordoquy, T.J. (2021). The effect of repeat administration of lipoplexes on gene delivery, biodistribution, and cytokine response in immunocompetent tumor-bearing mice. J. Pharm. Sci.","DOI":"10.1016\/j.xphs.2021.12.017"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.omto.2020.11.006","article-title":"Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer","volume":"20","author":"Barton","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/icb.2016.73","article-title":"Role of MyD88 in adenovirus keratitis","volume":"95","author":"Zhou","year":"2017","journal-title":"Immunol. Cell Biol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","article-title":"Molecular mechanisms and cellular functions of cGAS-STING signalling","volume":"21","author":"Hopfner","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Stichling, N., Suomalainen, M., Flatt, J.W., Schmid, M., Pacesa, M., Hemmi, S., Jungraithmayr, W., Maler, M.D., Freudenberg, M.A., and Pluckthun, A. (2018). Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor. PLoS Pathog., 14.","DOI":"10.1371\/journal.ppat.1006914"}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/5\/888\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:00:00Z","timestamp":1760137200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/5\/888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,24]]},"references-count":118,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["v14050888"],"URL":"https:\/\/doi.org\/10.3390\/v14050888","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,24]]}}}